Logo image of MYTE

MYT NETHERLANDS PARENT BV (MYTE) Stock Fundamental Analysis

NYSE:MYTE - New York Stock Exchange, Inc. - US55406W1036 - ADR - Currency: USD

7.64  -0.2 (-2.55%)

Fundamental Rating

3

MYTE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. MYTE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, MYTE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MYTE was profitable.
MYTE had a negative operating cash flow in the past year.
In the past 5 years MYTE reported 4 times negative net income.
In multiple years MYTE reported negative operating cash flow during the last 5 years.
MYTE Yearly Net Income VS EBIT VS OCF VS FCFMYTE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

With a Return On Assets value of -5.01%, MYTE is not doing good in the industry: 68.85% of the companies in the same industry are doing better.
MYTE has a Return On Equity of -8.64%. This is comparable to the rest of the industry: MYTE outperforms 42.62% of its industry peers.
MYTE has a Return On Invested Capital of 0.05%. This is in the lower half of the industry: MYTE underperforms 63.93% of its industry peers.
Industry RankSector Rank
ROA -5.01%
ROE -8.64%
ROIC 0.05%
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
MYTE Yearly ROA, ROE, ROICMYTE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

With a Operating Margin value of 0.03%, MYTE is not doing good in the industry: 63.93% of the companies in the same industry are doing better.
MYTE has a better Gross Margin (47.04%) than 72.13% of its industry peers.
MYTE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.03%
PM (TTM) N/A
GM 47.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
MYTE Yearly Profit, Operating, Gross MarginsMYTE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MYTE is destroying value.
The number of shares outstanding for MYTE has been increased compared to 1 year ago.
MYTE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MYTE has an improved debt to assets ratio.
MYTE Yearly Shares OutstandingMYTE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MYTE Yearly Total Debt VS Total AssetsMYTE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 4.23 indicates that MYTE is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.23, MYTE belongs to the best of the industry, outperforming 86.07% of the companies in the same industry.
A Debt/Equity ratio of 0.19 indicates that MYTE is not too dependend on debt financing.
MYTE has a Debt to Equity ratio of 0.19. This is in the better half of the industry: MYTE outperforms 61.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 4.23
ROIC/WACC0.01
WACC7.41%
MYTE Yearly LT Debt VS Equity VS FCFMYTE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.78 indicates that MYTE should not have too much problems paying its short term obligations.
The Current ratio of MYTE (1.78) is better than 76.23% of its industry peers.
A Quick Ratio of 0.22 indicates that MYTE may have some problems paying its short term obligations.
MYTE has a worse Quick ratio (0.22) than 85.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.22
MYTE Yearly Current Assets VS Current LiabilitesMYTE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

6

3. Growth

3.1 Past

MYTE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 525.00%, which is quite impressive.
The Revenue has grown by 11.84% in the past year. This is quite good.
Measured over the past years, MYTE shows a quite strong growth in Revenue. The Revenue has been growing by 17.27% on average per year.
EPS 1Y (TTM)525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)11.84%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%13.17%

3.2 Future

MYTE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.63% yearly.
Based on estimates for the next years, MYTE will show a quite strong growth in Revenue. The Revenue will grow by 9.58% on average per year.
EPS Next Y291%
EPS Next 2Y115.23%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue Next Year9.06%
Revenue Next 2Y9.71%
Revenue Next 3Y9.58%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MYTE Yearly Revenue VS EstimatesMYTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 500M 1B 1.5B
MYTE Yearly EPS VS EstimatesMYTE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MYTE is valuated quite expensively with a Price/Earnings ratio of 27.29.
The rest of the industry has a similar Price/Earnings ratio as MYTE.
MYTE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.70.
A Price/Forward Earnings ratio of 18.32 indicates a rather expensive valuation of MYTE.
MYTE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MYTE is cheaper than 61.48% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MYTE to the average of the S&P500 Index (22.49), we can say MYTE is valued inline with the index average.
Industry RankSector Rank
PE 27.29
Fwd PE 18.32
MYTE Price Earnings VS Forward Price EarningsMYTE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

67.21% of the companies in the same industry are cheaper than MYTE, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 49.69
MYTE Per share dataMYTE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MYTE's earnings are expected to grow with 54.63% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y115.23%
EPS Next 3Y54.63%

More info and screens

0

5. Dividend

5.1 Amount

MYTE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYT NETHERLANDS PARENT BV

NYSE:MYTE (4/30/2025, 8:23:38 PM)

7.64

-0.2 (-2.55%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)02-11 2025-02-11/bmo
Earnings (Next)05-14 2025-05-14/bmo
Inst OwnersN/A
Inst Owner Change11.59%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.04B
Analysts76.36
Price Target10.71 (40.18%)
Short Float %2.07%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.51%
Min EPS beat(2)96.08%
Max EPS beat(2)206.95%
EPS beat(4)2
Avg EPS beat(4)50.27%
Min EPS beat(4)-50.98%
Max EPS beat(4)206.95%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.32%
Min Revenue beat(2)-3.03%
Max Revenue beat(2)0.39%
Revenue beat(4)1
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)0.39%
Revenue beat(8)3
Avg Revenue beat(8)-0.99%
Revenue beat(12)4
Avg Revenue beat(12)-1.89%
Revenue beat(16)7
Avg Revenue beat(16)-0.73%
PT rev (1m)0%
PT rev (3m)49.57%
EPS NQ rev (1m)-140.01%
EPS NQ rev (3m)-111.77%
EPS NY rev (1m)0%
EPS NY rev (3m)17.95%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.97%
Valuation
Industry RankSector Rank
PE 27.29
Fwd PE 18.32
P/S 1.05
P/FCF N/A
P/OCF N/A
P/B 2.23
P/tB 3.57
EV/EBITDA 49.69
EPS(TTM)0.28
EY3.66%
EPS(NY)0.42
Fwd EY5.46%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS7.27
BVpS3.42
TBVpS2.14
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.01%
ROE -8.64%
ROCE 0.06%
ROIC 0.05%
ROICexc 0.05%
ROICexgc 0.07%
OM 0.03%
PM (TTM) N/A
GM 47.04%
FCFM N/A
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
F-Score3
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA 4.11
Cap/Depr 47.13%
Cap/Sales 1.02%
Interest Coverage 0.05
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.22
Altman-Z 4.23
F-Score3
WACC7.41%
ROIC/WACC0.01
Cap/Depr(3y)134.72%
Cap/Depr(5y)94.09%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y291%
EPS Next 2Y115.23%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue 1Y (TTM)11.84%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%13.17%
Revenue Next Year9.06%
Revenue Next 2Y9.71%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
EBIT growth 1Y101.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year188.35%
EBIT Next 3Y67.88%
EBIT Next 5YN/A
FCF growth 1Y18.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-407.95%
OCF growth 3YN/A
OCF growth 5Y33.41%